Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.

Perego M, Madzo J, Kossenkov AV, Atilgan FC, Tazzari M, Tumedei MM, Limarzi F, Lolli C, Gurioli G, Fatatis A, Iacocca MV, Petrelli NJ, Jacobi JJ, Goodrich DW, Languino LR, Altieri DC

Open source

DOI: 10.1038/s41388-026-03969-5
Published: 2026 Sep 1
Container: Oncogene
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41388-026-03969-5,
  title = {Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.},
  author = {Perego M and Madzo J and Kossenkov AV and Atilgan FC and Tazzari M and Tumedei MM and Limarzi F and Lolli C and Gurioli G and Fatatis A and Iacocca MV and Petrelli NJ and Jacobi JJ and Goodrich DW and Languino LR and Altieri DC},
  year = {2026},
  journal = {Oncogene},
  doi = {10.1038/s41388-026-03969-5},
  url = {https://doi.org/10.1038/s41388-026-03969-5}
}

RIS

TY  - JOUR
TI  - Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.
AU  - Perego M
AU  - Madzo J
AU  - Kossenkov AV
AU  - Atilgan FC
AU  - Tazzari M
AU  - Tumedei MM
AU  - Limarzi F
AU  - Lolli C
AU  - Gurioli G
AU  - Fatatis A
AU  - Iacocca MV
AU  - Petrelli NJ
AU  - Jacobi JJ
AU  - Goodrich DW
AU  - Languino LR
AU  - Altieri DC
PY  - 2026
JO  - Oncogene
DO  - 10.1038/s41388-026-03969-5
UR  - https://doi.org/10.1038/s41388-026-03969-5
ER  -

APA

M, P., J, M., AV, K., FC, A., M, T., MM, T., F, L., C, L., G, G., A, F., MV, I., NJ, P., JJ, J., DW, G., LR, L., & DC, A. (2026). Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.. Oncogene. https://doi.org/10.1038/s41388-026-03969-5

Source records

pubmed · retrieved 2026-09-26T14:59:02.465Z